Alkermes plc
US ˙ NasdaqGS ˙ IE00B56GVS15

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Richard F Pops. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Richard F Pops har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:NBIX / Neurocrine Biosciences, Inc. Director 34.480
US:ALKS / Alkermes plc Director and CEO, Alkermes plc, Director 1.290.390
US:EPZM / Epizyme Inc Director 14.013
US:XLRN / Acceleron Pharma Inc Director 7.500
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Richard F Pops. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb ALKS / Alkermes plc – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i ALKS / Alkermes plc. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ALKS / Alkermes plc Insider Trades
Insidersalg ALKS / Alkermes plc – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i ALKS / Alkermes plc. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2022-05-06 ALKS POPS RICHARD F 93.747 27,8549 93.747 27,8549 2.611.313 157 21.9400 -554.504 -21,23
2022-05-05 ALKS POPS RICHARD F 221.222 27,9504 221.222 27,9504 6.183.243
2022-05-05 ALKS POPS RICHARD F 32.288 28,5935 32.288 28,5935 923.227

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

ALKS / Alkermes plc Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Richard F Pops som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-05-22 2025-05-22 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 2.869 34.480 9,08
2025-02-07 2025-02-06 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -79.925 1.290.390 -5,83 31,39 -2.508.846 40.505.342
2025-02-07 2025-02-06 4 ALKS Alkermes plc.
Ordinary Shares
A - Award 190.640 1.370.315 16,16
2024-05-21 2024-05-17 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -2.100 31.611 -6,23 141,84 -297.860 4.483.651
2024-05-21 2024-05-17 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 4.199 33.711 14,23
2024-03-15 2024-03-13 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -23.200 29.512 -44,01 140,33 -3.255.621 4.141.375
2024-03-15 2024-03-13 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 23.200 52.712 78,61 42,76 992.032 2.253.965
2024-03-12 2024-03-11 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -100 29.512 -0,34 140,00 -14.000 4.131.680
2024-03-12 2024-03-11 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 100 29.612 0,34 42,76 4.276 1.266.209
2024-03-12 2024-03-08 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -1.700 29.512 -5,45 140,05 -238.078 4.133.035
2024-03-12 2024-03-08 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 1.700 31.212 5,76 42,76 72.692 1.334.625
2024-02-22 2024-02-20 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -15.000 29.512 -33,70 132,47 -1.987.047 3.909.449
2024-02-22 2024-02-20 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 15.000 44.512 50,83 12,98 194.700 577.766
2024-02-12 2024-02-08 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -91.757 1.179.675 -7,22 26,77 -2.456.335 31.579.900
2024-02-12 2024-02-08 4 ALKS Alkermes plc.
Ordinary Shares
A - Award 218.551 1.271.432 20,76
2023-02-22 2023-02-21 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -14.386 1.052.881 -1,35 27,77 -399.499 29.238.505
2023-02-22 2023-02-21 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 32.400 1.067.267 3,13
2023-02-22 2023-02-20 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -53.145 1.034.867 -4,88 28,07 -1.491.780 29.048.717
2023-02-22 2023-02-20 4 ALKS Alkermes plc.
Ordinary Shares
A - Award 119.713 1.088.012 12,36
2023-01-05 2023-01-03 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -15.000 29.512 -33,70 119,20 -1.788.045 3.517.919
2023-01-05 2023-01-03 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 15.000 44.512 50,83 12,71 190.650 565.748
2022-05-20 2022-05-18 4 NBIX NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option
A - Award 9.724 9.724
2022-05-11 2022-05-09 4 NBIX NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option
M - Exercise -7.500 0 -100,00 6,66 -49.950
2022-05-11 2022-05-09 4 NBIX NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option
M - Exercise -7.500 0 -100,00 6,66 -49.950
2022-05-11 2022-05-09 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -7.500 29.512 -20,26 76,30 -572.252 2.251.772
2022-05-11 2022-05-09 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 7.500 37.012 25,41 6,66 49.950 246.500
2022-05-11 2022-05-09 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 7.500 37.012 25,41 6,66 49.950 246.500
2022-05-11 2022-05-09 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -7.500 29.512 -20,26 76,29 -572.211 2.251.612
2022-05-06 2022-05-06 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise -120.847 0 -100,00
2022-05-06 2022-05-06 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale -93.747 968.299 -8,83 27,85 -2.611.313 26.971.872
2022-05-06 2022-05-06 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 120.847 1.062.046 12,84 16,55 2.000.018 17.576.861
2022-05-06 2022-05-05 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise -329.153 120.847 -73,15
2022-05-06 2022-05-05 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale -32.288 941.199 -3,32 28,59 -923.227 26.912.174
2022-05-06 2022-05-05 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale -221.222 973.487 -18,52 27,95 -6.183.243 27.209.351
2022-05-06 2022-05-05 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 329.153 1.194.709 38,03 16,55 5.447.482 19.772.434
2022-02-23 2022-02-21 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -32.400 32.400 -50,00
2022-02-23 2022-02-21 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -14.386 865.556 -1,63 25,08 -360.801 21.708.144
2022-02-23 2022-02-21 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 32.400 879.942 3,82
2022-02-23 2022-02-18 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 299.044 299.044
2022-02-17 2022-02-16 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -18.125 0 -100,00
2022-02-17 2022-02-16 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -8.038 847.542 -0,94 26,79 -215.338 22.705.650
2022-02-17 2022-02-16 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 18.125 855.580 2,16
2021-09-16 2021-09-14 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -36.267 837.455 -4,15 30,60 -1.109.770 25.626.123
2021-09-16 2021-09-14 4 ALKS Alkermes plc.
Ordinary Shares
A - Award 81.682 873.722 10,31
2021-05-20 2021-05-19 4 NBIX NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option
A - Award 8.833 8.833
2021-05-19 2021-05-18 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -150.000 0 -100,00
2021-05-19 2021-05-18 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -150.000 792.040 -15,92 21,90 -3.285.405 17.347.815
2021-05-19 2021-05-18 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 150.000 942.040 18,94 18,10 2.715.750 17.055.634
2021-05-12 2021-05-11 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -150.000 150.000 -50,00
2021-05-12 2021-05-11 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -60.297 792.040 -7,07 22,30 -1.344.798 17.664.789
2021-05-12 2021-05-11 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -89.703 852.337 -9,52 21,95 -1.968.541 18.704.621
2021-05-12 2021-05-11 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 150.000 942.040 18,94 18,10 2.715.750 17.055.634
2021-05-07 2021-05-06 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -100.000 300.000 -25,00
2021-05-07 2021-05-06 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -100.000 792.040 -11,21 21,79 -2.179.410 17.261.799
2021-05-07 2021-05-06 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 100.000 892.040 12,63 18,10 1.810.500 16.150.384
2021-02-24 2021-02-22 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 342.187 342.187
2021-02-23 2021-02-21 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -32.400 64.800 -33,33
2021-02-23 2021-02-21 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -14.386 792.040 -1,78 19,58 -281.678 15.508.143
2021-02-23 2021-02-21 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 32.400 806.426 4,19
2021-02-18 2021-02-17 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -8.750 0 -100,00
2021-02-18 2021-02-17 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -3.869 774.026 -0,50 19,97 -77.264 15.457.299
2021-02-18 2021-02-17 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8.750 777.895 1,14
2021-02-18 2021-02-16 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -18.125 18.125 -50,00
2021-02-18 2021-02-16 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -8.074 769.145 -1,04 19,79 -159.784 15.221.380
2021-02-18 2021-02-16 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 18.125 777.219 2,39
2020-06-02 2020-05-29 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 14.013 14.013
2020-05-21 2020-05-19 4 NBIX NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option
A - Award 6.018 6.018
2020-05-14 2020-05-14 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -75.000 0 -100,00
2020-05-14 2020-05-14 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -75.000 759.094 -8,99 15,00 -1.125.232 11.388.763
2020-05-14 2020-05-14 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 75.000 834.094 9,88 11,74 880.500 9.792.264
2020-05-07 2020-05-07 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -50.000 75.000 -40,00
2020-05-07 2020-05-07 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -50.000 759.094 -6,18 14,63 -731.265 11.101.977
2020-05-07 2020-05-07 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50.000 809.094 6,59 11,74 587.000 9.498.764
2020-04-03 2020-04-02 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -50.000 125.000 -28,57
2020-04-03 2020-04-02 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -50.000 759.094 -6,18 13,79 -689.500 10.467.906
2020-04-03 2020-04-02 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50.000 809.094 6,59 11,74 587.000 9.498.764
2020-03-26 2020-03-26 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -75.000 175.000 -30,00
2020-03-26 2020-03-26 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -75.000 759.094 -8,99 14,36 -1.077.225 10.902.867
2020-03-26 2020-03-26 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 75.000 834.094 9,88 11,74 880.500 9.792.264
2020-03-19 2020-03-19 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -75.000 250.000 -23,08
2020-03-19 2020-03-19 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -15.986 759.094 -2,06 15,04 -240.393 11.415.028
2020-03-19 2020-03-19 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -48.668 775.080 -5,91 14,51 -706.168 11.246.333
2020-03-19 2020-03-19 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -10.346 823.748 -1,24 13,42 -138.867 11.056.593
2020-03-19 2020-03-19 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 75.000 834.094 9,88 11,74 880.500 9.792.264
2020-03-03 2020-03-01 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -17.500 0 -100,00
2020-03-03 2020-03-01 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -7.770 759.094 -1,01 20,84 -161.927 15.819.519
2020-03-03 2020-03-01 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 17.500 766.864 2,34
2020-02-24 2020-02-21 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -32.400 97.200 -25,00
2020-02-24 2020-02-21 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -14.386 749.364 -1,88 20,24 -291.173 15.167.127
2020-02-24 2020-02-21 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 32.400 763.750 4,43
2020-02-24 2020-02-20 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 358.466 358.466
2020-02-18 2020-02-17 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -8.750 8.750 -50,00
2020-02-18 2020-02-17 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -3.886 731.350 -0,53 17,77 -69.054 12.996.090
2020-02-18 2020-02-17 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8.750 735.236 1,20
2020-02-18 2020-02-16 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -18.125 36.250 -33,33
2020-02-18 2020-02-16 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -8.072 726.486 -1,10 17,77 -143.439 12.909.656
2020-02-18 2020-02-16 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 18.125 734.558 2,53
2019-11-15 2019-11-14 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -100.000 0 -100,00
2019-11-15 2019-11-14 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -100.000 716.433 -12,25 19,50 -1.950.000 13.970.444
2019-11-15 2019-11-14 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 100.000 816.433 13,96 9,21 921.000 7.519.348
2019-11-08 2019-11-08 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -30.205 100.000 -23,20
2019-11-08 2019-11-08 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -30.205 716.433 -4,05 19,73 -595.827 14.132.429
2019-11-08 2019-11-08 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 30.205 746.638 4,22 9,21 278.188 6.876.536
2019-11-08 2019-11-07 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -69.795 130.205 -34,90
2019-11-08 2019-11-07 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -69.795 716.433 -8,88 19,81 -1.382.618 14.192.323
2019-11-08 2019-11-07 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 69.795 786.228 9,74 9,21 642.812 7.241.160
2019-09-23 2019-09-19 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -100.000 200.000 -33,33
2019-09-23 2019-09-19 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -100.000 716.433 -12,25 21,54 -2.153.550 15.428.743
2019-09-23 2019-09-19 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 100.000 816.433 13,96 9,21 921.000 7.519.348
2019-09-13 2019-09-12 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -100.000 300.000 -25,00
2019-09-13 2019-09-12 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -100.000 716.433 -12,25 22,68 -2.268.220 16.250.277
2019-09-13 2019-09-12 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 100.000 816.433 13,96 9,21 921.000 7.519.348
2019-09-06 2019-09-05 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -100.000 400.000 -20,00
2019-09-06 2019-09-05 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -100.000 716.433 -12,25 20,18 -2.017.830 14.456.400
2019-09-06 2019-09-05 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 100.000 816.433 13,96 9,21 921.000 7.519.348
2019-06-07 2019-05-31 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 17.633 17.633
2019-05-24 2019-05-23 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -50.000 0 -100,00
2019-05-24 2019-05-23 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -50.000 716.433 -6,52 24,22 -1.211.150 17.354.157
2019-05-24 2019-05-23 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50.000 766.433 6,98 8,55 427.500 6.553.002
2019-05-24 2019-05-16 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -60.000 50.000 -54,55
2019-05-24 2019-05-16 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -60.000 716.433 -7,73 25,42 -1.525.278 18.212.658
2019-05-24 2019-05-16 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 60.000 776.433 8,37 8,55 513.000 6.638.502
2019-05-23 2019-05-22 4 NBIX NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option
A - Award 10.000 10.000
2019-03-14 2019-03-13 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -15.829 110.000 -12,58
2019-03-14 2019-03-13 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -15.829 716.433 -2,16 33,51 -530.485 24.010.177
2019-03-14 2019-03-13 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 15.829 732.262 2,21 8,55 135.338 6.260.840
2019-03-14 2019-03-12 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -44.171 125.829 -25,98
2019-03-14 2019-03-12 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -44.171 716.433 -5,81 33,24 -1.468.447 23.817.529
2019-03-14 2019-03-12 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 44.171 760.604 6,17 8,55 377.662 6.503.164
2019-03-07 2019-03-05 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -50.000 170.000 -22,73
2019-03-07 2019-03-05 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -50.000 716.433 -6,52 33,63 -1.681.740 24.097.081
2019-03-07 2019-03-05 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50.000 766.433 6,98 8,55 427.500 6.553.002
2019-03-04 2019-03-01 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -17.500 17.500 -50,00
2019-03-04 2019-03-01 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -7.770 716.433 -1,07 34,44 -267.599 24.673.953
2019-03-04 2019-03-01 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 17.500 724.203 2,48
2019-02-27 2019-02-26 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -10.000 0 -100,00
2019-02-27 2019-02-26 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -3.887 706.703 -0,55 33,92 -131.847 23.971.366
2019-02-27 2019-02-26 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 10.000 710.590 1,43
2019-02-25 2019-02-21 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 382.200 382.200
2019-02-25 2019-02-21 4 ALKS Alkermes plc.
Restricted Stock Unit Award
A - Award 129.600 129.600
2019-02-25 2019-02-21 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 121.000 121.000
2019-02-19 2019-02-17 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -8.750 17.500 -33,33
2019-02-19 2019-02-17 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -2.573 700.590 -0,37 32,54 -83.725 22.797.199
2019-02-19 2019-02-17 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8.750 703.163 1,26
2019-02-19 2019-02-16 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -18.125 54.375 -25,00
2019-02-19 2019-02-16 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -5.340 694.413 -0,76 32,54 -173.764 22.596.199
2019-02-19 2019-02-16 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 18.125 699.753 2,66
2019-01-29 2019-01-25 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 7.500 7.500
2019-01-29 2019-01-25 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 1.250 32.500 4,00
2018-12-11 2018-12-07 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -12.224 681.628 -1,76 34,01 -415.738 23.182.168
2018-12-11 2018-12-07 4 ALKS Alkermes plc.
Ordinary Shares
A - Award 27.500 693.852 4,13
2018-11-27 2018-11-26 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -4.124 29.512 -12,26 91,37 -376.790 2.696.367
2018-11-13 2018-11-12 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -4.123 33.636 -10,92 103,30 -425.893 3.474.491
2018-10-30 2018-10-29 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -5.500 37.759 -12,71 107,13 -589.237 4.045.273
2018-05-31 2018-05-18 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 12.500 12.500
2018-05-25 2018-05-24 4 NBIX NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option
A - Award 12.500 12.500
2018-05-24 2018-05-22 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -20.000 0 -100,00
2018-05-24 2018-05-22 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -3.682 666.352 -0,55 46,03 -169.495 30.674.382
2018-05-24 2018-05-22 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -16.318 670.034 -2,38 45,33 -739.669 30.371.569
2018-05-24 2018-05-22 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 20.000 686.352 3,00 12,29 245.800 8.435.266
2018-05-17 2018-05-15 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -50.000 20.000 -71,43
2018-05-17 2018-05-15 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -50.000 666.352 -6,98 46,38 -2.319.100 30.906.738
2018-05-17 2018-05-15 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50.000 716.352 7,50 12,29 614.500 8.803.966
2018-05-10 2018-05-08 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -50.000 70.000 -41,67
2018-05-10 2018-05-08 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -7.360 666.352 -1,09 44,55 -327.863 29.683.716
2018-05-10 2018-05-08 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -42.640 673.712 -5,95 44,28 -1.887.912 29.829.003
2018-05-10 2018-05-08 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50.000 716.352 7,50 12,29 614.500 8.803.966
2018-05-03 2018-05-01 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -50.000 120.000 -29,41
2018-05-03 2018-05-01 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -900 666.352 -0,13 44,66 -40.197 29.761.479
2018-05-03 2018-05-01 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -49.100 667.252 -6,85 44,01 -2.160.970 29.366.828
2018-05-03 2018-05-01 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50.000 716.352 7,50 12,29 614.500 8.803.966
2018-05-03 2018-05-01 4 NBIX NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option
M - Exercise 15.000 0 -100,00 7,05 105.750
2018-05-03 2018-05-01 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
F - Taxes -1.253 43.259 -2,81 84,39 -105.741 3.650.627
2018-05-03 2018-05-01 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 15.000 44.512 50,83 7,05 105.750 313.810
2018-03-08 2018-03-06 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
M - Exercise -37.500 0 -100,00
2018-03-08 2018-03-06 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale -2.902 31.250 -8,50 42,32 -122.813 1.322.500
2018-03-08 2018-03-06 4 XLRN ACCELERON PHARMA INC
Common Stock
S - Sale -34.598 34.152 -50,32 41,34 -1.430.281 1.411.844
2018-03-08 2018-03-06 4 XLRN ACCELERON PHARMA INC
Common Stock
M - Exercise 37.500 68.750 120,00 5,08 190.500 349.250
2018-03-05 2018-03-01 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 7.500 7.500
2018-03-05 2018-03-01 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 1.250 31.250 4,17
2018-03-05 2018-03-03 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -13.000 0 -100,00
2018-03-05 2018-03-03 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -5.779 666.352 -0,86 60,05 -347.029 40.014.438
2018-03-05 2018-03-03 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 13.000 672.131 1,97
2018-03-05 2018-03-01 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -17.500 35.000 -33,33
2018-03-05 2018-03-01 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -7.779 659.131 -1,17 57,41 -446.592 37.840.711
2018-03-05 2018-03-01 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 17.500 666.910 2,69
2018-02-28 2018-02-26 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -10.000 10.000 -50,00
2018-02-28 2018-02-26 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -4.445 649.410 -0,68 58,12 -258.343 37.743.709
2018-02-28 2018-02-26 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 10.000 653.855 1,55
2018-02-21 2018-02-17 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -8.750 26.250 -25,00
2018-02-21 2018-02-17 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -2.581 643.855 -0,40 67,26 -173.598 43.305.687
2018-02-21 2018-02-17 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8.750 646.436 1,37
2018-02-21 2018-02-16 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 295.000 295.000
2018-02-21 2018-02-16 4 ALKS Alkermes plc.
Restricted Stock Unit Award
A - Award 72.500 72.500
2017-11-03 2017-11-02 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
M - Exercise X -50.000 0 -100,00
2017-11-03 2017-11-02 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -50.000 637.686 -7,27 48,87 -2.443.410 31.162.567
2017-11-03 2017-11-02 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50.000 687.686 7,84 14,13 706.500 9.717.003
2017-06-26 2017-06-22 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 12.500 12.500
2017-06-08 2017-05-22 4 NBIX NEUROCRINE BIOSCIENCES INC
Stock Option
A - Award 15.000 15.000
2017-05-30 2017-05-28 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -13.750 0 -100,00
2017-05-30 2017-05-28 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -6.470 637.686 -1,00 57,70 -373.319 36.794.482
2017-05-30 2017-05-28 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 13.750 644.156 2,18
2017-05-25 2017-05-24 4 ALKS Alkermes plc.
Incentive Stock Option (Right to Buy)
M - Exercise X -6.269 0 -100,00
2017-05-25 2017-05-24 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -18.731 0 -100,00
2017-05-25 2017-05-24 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -25.000 630.406 -3,81 57,42 -1.435.535 36.198.795
2017-05-25 2017-05-24 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 6.269 655.406 0,97 15,95 99.991 10.453.726
2017-05-25 2017-05-24 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 18.731 649.137 2,97 15,95 298.759 10.353.735
2017-05-19 2017-05-17 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -50.000 18.731 -72,75
2017-05-19 2017-05-17 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -5.939 630.406 -0,93 59,06 -350.743 37.230.265
2017-05-19 2017-05-17 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -32.406 636.345 -4,85 58,37 -1.891.639 37.145.430
2017-05-19 2017-05-17 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -11.655 668.751 -1,71 57,23 -667.058 38.275.027
2017-05-19 2017-05-17 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50.000 680.406 7,93 15,95 797.500 10.852.476
2017-05-11 2017-05-10 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -25.000 68.731 -26,67
2017-05-11 2017-05-10 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -7.841 630.406 -1,23 57,67 -452.156 36.352.740
2017-05-11 2017-05-10 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -17.159 638.247 -2,62 57,12 -980.088 36.455.392
2017-05-11 2017-05-10 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 25.000 655.406 3,97 15,95 398.750 10.453.726
2017-05-05 2017-05-03 4 NBIX NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option
M - Exercise -15.000 0 -100,00
2017-05-05 2017-05-03 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
F - Taxes -952 29.512 -3,12 53,37 -50.808 1.575.055
2017-05-05 2017-05-03 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 15.000 30.454 97,06 3,40 51.000 103.544
2017-03-14 2017-03-02 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 7.500 7.500
2017-03-14 2017-03-02 4 XLRN ACCELERON PHARMA INC
Common Stock
A - Award 1.250 30.000 4,35
2017-03-06 2017-03-03 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -13.000 13.000 -50,00
2017-03-06 2017-03-03 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -6.117 630.406 -0,96 60,97 -372.953 38.435.854
2017-03-06 2017-03-03 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 13.000 636.523 2,08
2017-03-02 2017-03-01 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -17.500 52.500 -25,00
2017-03-02 2017-03-01 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -8.234 623.523 -1,30 59,71 -491.652 37.230.558
2017-03-02 2017-03-01 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 17.500 631.757 2,85
2017-02-27 2017-02-26 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -10.000 20.000 -33,33
2017-02-27 2017-02-26 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -4.705 614.257 -0,76 52,98 -249.271 32.543.336
2017-02-27 2017-02-26 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 10.000 618.962 1,64
2017-02-21 2017-02-17 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 200.000 200.000
2017-02-21 2017-02-17 4 ALKS Alkermes plc.
Restricted Stock Unit Award
A - Award 35.000 35.000
2016-11-30 2016-11-29 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -30.000 0 -100,00
2016-11-30 2016-11-29 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -2.050 608.962 -0,34 57,72 -118.320 35.147.642
2016-11-30 2016-11-29 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -27.950 611.012 -4,37 56,93 -1.591.149 34.783.936
2016-11-30 2016-11-29 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 30.000 638.962 4,93 14,38 431.400 9.188.274
2016-11-22 2016-11-22 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -30.000 30.000 -50,00
2016-11-22 2016-11-22 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -6.885 608.962 -1,12 59,44 -409.218 36.194.326
2016-11-22 2016-11-22 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -23.115 615.847 -3,62 58,43 -1.350.718 35.986.835
2016-11-22 2016-11-22 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 30.000 638.962 4,93 14,38 431.400 9.188.274
2016-11-17 2016-11-15 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -30.000 60.000 -33,33
2016-11-17 2016-11-15 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -2.060 608.962 -0,34 59,29 -122.133 36.104.200
2016-11-17 2016-11-15 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -27.940 611.022 -4,37 58,78 -1.642.391 35.917.584
2016-11-17 2016-11-15 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 30.000 638.962 4,93 14,38 431.400 9.188.274
2016-11-10 2016-11-08 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -30.000 90.000 -25,00
2016-11-10 2016-11-08 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -8.946 608.962 -1,45 53,82 -481.466 32.773.787
2016-11-10 2016-11-08 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -21.054 617.908 -3,30 53,05 -1.116.997 32.782.429
2016-11-10 2016-11-08 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 30.000 638.962 4,93 14,38 431.400 9.188.274
2016-10-07 2016-10-05 4 ALKS Alkermes plc.
Performance Restricted Stock Units
M - Exercise -20.000 0 -100,00
2016-10-07 2016-10-05 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -9.410 608.962 -1,52 46,43 -436.906 28.274.106
2016-10-07 2016-10-05 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 20.000 618.372 3,34
2016-06-01 2016-05-28 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -13.750 13.750 -50,00
2016-06-01 2016-05-28 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 13.750 598.372 2,35
2016-05-26 2016-05-25 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
S - Sale X -15.000 15.464 -49,24 46,72 -700.800 722.478
2016-05-24 2016-05-20 4 NBIX NEUROCRINE BIOSCIENCES INC
Stock Option
A - Award 15.000 15.000
2016-05-24 2015-05-28 4/A NBIX NEUROCRINE BIOSCIENCES INC
Stock Option
A - Award 25.000 25.000
2016-05-23 2016-05-19 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 12.500 12.500
2016-05-23 2016-05-21 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -8.125 0 -100,00
2016-05-23 2016-05-21 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8.125 584.622 1,41
2016-05-18 2016-05-16 4 NBIX NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option
M - Exercise -15.000 0 -100,00
2016-05-18 2016-05-16 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
F - Taxes -1.008 30.464 -3,20 45,64 -46.005 1.390.377
2016-05-18 2016-05-16 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 15.000 31.472 91,06 3,07 46.050 96.619
2016-04-20 2016-04-19 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -18.750 0 -100,00
2016-04-20 2016-04-19 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -18.750 576.497 -3,15 40,15 -752.863 23.147.911
2016-04-20 2016-04-19 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 18.750 595.247 3,25 20,79 389.812 12.375.185
2016-04-13 2016-04-12 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -25.000 18.750 -57,14
2016-04-13 2016-04-12 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -1.700 576.497 -0,29 38,24 -65.008 22.045.245
2016-04-13 2016-04-12 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -23.300 578.197 -3,87 37,76 -879.831 21.833.297
2016-04-13 2016-04-12 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 25.000 601.497 4,34 20,79 519.750 12.505.123
2016-03-23 2016-03-22 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -25.000 43.750 -36,36
2016-03-23 2016-03-22 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -15.000 576.497 -2,54 32,05 -480.717 18.475.461
2016-03-23 2016-03-22 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -10.000 591.497 -1,66 31,36 -313.636 18.551.475
2016-03-23 2016-03-22 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 25.000 601.497 4,34 20,79 519.750 12.505.123
2016-03-16 2016-03-15 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -20.190 68.750 -22,70
2016-03-16 2016-03-15 4 ALKS Alkermes plc.
Incentive Stock Option (Right to Buy)
M - Exercise X -4.810 0 -100,00
2016-03-16 2016-03-15 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -25.000 576.497 -4,16 31,40 -784.910 18.099.930
2016-03-16 2016-03-15 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 20.190 601.497 3,47 20,79 419.750 12.505.123
2016-03-16 2016-03-15 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 4.810 581.307 0,83 20,79 100.000 12.085.373
2016-03-07 2016-03-03 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 10.000 10.000
2016-03-04 2016-03-03 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -13.000 26.000 -33,33
2016-03-04 2016-03-03 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 13.000 576.497 2,31
2016-03-01 2016-02-29 4 ALKS Alkermes plc.
Restricted Stock Unit Award
A - Award 70.000 70.000
2016-03-01 2016-02-29 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 300.000 300.000
2016-03-01 2016-02-26 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -10.000 30.000 -25,00
2016-03-01 2016-02-26 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 10.000 563.497 1,81
2015-12-08 2015-12-07 4 ALKS Alkermes plc.
Incentive Stock Option (Right to Buy)
M - Exercise X -5.376 0 -100,00
2015-12-08 2015-12-07 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -32.124 0 -100,00
2015-12-08 2015-12-07 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -882 553.497 -0,16 73,52 -64.841 40.690.609
2015-12-08 2015-12-07 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -9.210 554.379 -1,63 72,51 -667.799 40.196.913
2015-12-08 2015-12-07 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -27.408 563.589 -4,64 71,87 -1.969.794 40.504.747
2015-12-08 2015-12-07 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 5.376 590.997 0,92 18,60 99.994 10.992.544
2015-12-08 2015-12-07 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 32.124 585.621 5,80 18,60 597.506 10.892.551
2015-12-02 2015-12-01 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -50.000 32.124 -60,88
2015-12-02 2015-12-01 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -2.200 553.497 -0,40 73,46 -161.602 40.657.454
2015-12-02 2015-12-01 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -24.052 555.697 -4,15 72,48 -1.743.171 40.274.196
2015-12-02 2015-12-01 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -23.748 579.749 -3,94 71,99 -1.709.571 41.734.971
2015-12-02 2015-12-01 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50.000 603.497 9,03 18,60 930.000 11.225.044
2015-10-07 2015-10-05 4 ALKS Alkermes plc.
Performance Restricted Stock Units
A - Award 20.000 20.000
2015-10-07 2015-10-05 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -9.420 553.497 -1,67 59,77 -563.033 33.082.516
2015-10-07 2015-10-05 4 ALKS Alkermes plc.
Ordinary Shares
A - Award 20.000 562.917 3,68
2015-09-17 2015-09-17 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -50.000 82.124 -37,84
2015-09-17 2015-09-17 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -27.579 542.917 -4,83 71,58 -1.974.072 38.861.347
2015-09-17 2015-09-17 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -22.421 570.496 -3,78 70,88 -1.589.189 40.436.471
2015-09-17 2015-09-17 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50.000 592.917 9,21 18,60 930.000 11.028.256
2015-09-10 2015-09-10 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -50.000 132.124 -27,45
2015-09-10 2015-09-10 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -20.009 542.917 -3,55 68,12 -1.363.013 36.983.506
2015-09-10 2015-09-10 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -29.991 562.926 -5,06 67,20 -2.015.374 37.828.233
2015-09-10 2015-09-10 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50.000 592.917 9,21 18,60 930.000 11.028.256
2015-07-10 2015-07-08 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 7.333 7.333
2015-06-01 2015-05-28 4 NBIX NEUROCRINE BIOSCIENCES INC
Stock Option
A - Award 25.000 25.000
2015-05-29 2015-05-28 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -13.750 27.500 -33,33
2015-05-29 2015-05-28 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -6.477 542.917 -1,18 59,92 -388.102 32.531.587
2015-05-29 2015-05-28 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 13.750 549.394 2,57
2015-05-22 2015-05-21 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -8.125 8.125 -50,00
2015-05-22 2015-05-21 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -3.827 535.644 -0,71 61,80 -236.509 33.102.799
2015-05-22 2015-05-21 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8.125 539.471 1,53
2015-05-22 2015-05-20 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -8.125 0 -100,00
2015-05-22 2015-05-20 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -3.827 531.346 -0,72 62,10 -237.657 32.996.587
2015-05-22 2015-05-20 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8.125 535.173 1,54
2015-05-13 2015-05-11 4 NBIX NEUROCRINE BIOSCIENCES INC
Non-Qualified Stock Option
M - Exercise -15.000 0 -100,00
2015-05-13 2015-05-11 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
F - Taxes -1.801 16.472 -9,86 39,63 -71.374 652.785
2015-05-13 2015-05-11 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 15.000 18.273 458,30 4,76 71.400 86.979
2015-04-08 2015-01-08 4/A XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 10.000 10.000
2015-03-05 2015-03-03 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -13.000 39.000 -25,00
2015-03-05 2015-03-03 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -6.123 526.940 -1,15 72,80 -445.754 38.361.232
2015-03-05 2015-03-03 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 13.000 533.063 2,50
2015-02-27 2015-02-26 4 ALKS Alkermes plc.
Restricted Stock Unit Award
A - Award 40.000 40.000
2015-02-27 2015-02-26 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 200.000 200.000
2015-01-09 2015-01-08 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 10.000 10.000
2014-12-11 2014-12-11 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -50.000 0 -100,00
2014-12-11 2014-12-11 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -4.621 520.063 -0,88 56,76 -262.292 29.519.192
2014-12-11 2014-12-11 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -45.379 524.684 -7,96 56,14 -2.547.759 29.457.858
2014-12-11 2014-12-11 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50.000 570.063 9,61 14,90 745.000 8.493.939
2014-12-11 2014-12-10 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -50.000 50.000 -50,00
2014-12-11 2014-12-10 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -1.500 520.063 -0,29 56,56 -84.837 29.413.567
2014-12-11 2014-12-10 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -48.500 521.563 -8,51 55,86 -2.709.302 29.135.500
2014-12-11 2014-12-10 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50.000 570.063 9,61 14,90 745.000 8.493.939
2014-11-13 2014-11-13 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -50.000 100.000 -33,33
2014-11-13 2014-11-13 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -50.000 520.063 -8,77 52,88 -2.643.990 27.500.827
2014-11-13 2014-11-13 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50.000 570.063 9,61 14,90 745.000 8.493.939
2014-11-13 2014-11-12 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -50.000 150.000 -25,00
2014-11-13 2014-11-12 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -50.000 520.063 -8,77 52,86 -2.643.175 27.492.350
2014-11-13 2014-11-12 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50.000 570.063 9,61 14,90 745.000 8.493.939
2014-10-16 2014-10-16 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -50.000 200.000 -20,00
2014-10-16 2014-10-16 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -31.800 520.063 -5,76 41,34 -1.314.488 21.497.376
2014-10-16 2014-10-16 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -18.200 551.863 -3,19 40,90 -744.424 22.572.521
2014-10-16 2014-10-16 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50.000 570.063 9,61 14,90 745.000 8.493.939
2014-10-16 2014-10-15 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -50.000 250.000 -16,67
2014-10-16 2014-10-15 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -12.700 520.063 -2,38 41,50 -527.096 21.584.487
2014-10-16 2014-10-15 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -37.300 532.763 -6,54 40,91 -1.526.014 21.796.347
2014-10-16 2014-10-15 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50.000 570.063 9,61 14,90 745.000 8.493.939
2014-09-19 2014-09-17 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -50.000 300.000 -14,29
2014-09-19 2014-09-17 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -50.000 520.063 -8,77 44,89 -2.244.585 23.346.512
2014-09-19 2014-09-17 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50.000 570.063 9,61 14,90 745.000 8.493.939
2014-07-25 2014-07-23 4 EPZM Epizyme, Inc.
Stock Option (Right to Buy)
A - Award 7.333 7.333
2014-07-07 2014-07-02 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -50.000 0 -100,00
2014-07-07 2014-07-02 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -1.400 520.063 -0,27 52,07 -72.904 27.082.073
2014-07-07 2014-07-02 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -48.600 521.463 -8,53 51,68 -2.511.463 26.947.226
2014-07-07 2014-07-02 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50.000 570.063 9,61 12,30 615.000 7.011.775
2014-06-27 2014-06-25 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -50.000 50.000 -50,00
2014-06-27 2014-06-25 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -200 520.063 -0,04 50,70 -10.140 26.367.194
2014-06-27 2014-06-25 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -49.800 520.263 -8,74 49,87 -2.483.546 25.945.724
2014-06-27 2014-06-25 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50.000 570.063 9,61 12,30 615.000 7.011.775
2014-06-20 2014-06-18 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -41.870 100.000 -29,51
2014-06-20 2014-06-18 4 ALKS Alkermes plc.
Incentive Stock Option (Right to Buy)
M - Exercise X -8.130 0 -100,00
2014-06-20 2014-06-18 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -1.300 520.063 -0,25 47,51 -61.765 24.709.025
2014-06-20 2014-06-18 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -48.700 521.363 -8,54 46,70 -2.274.246 24.347.183
2014-06-20 2014-06-18 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 41.870 570.063 7,93 12,30 515.001 7.011.775
2014-06-20 2014-06-18 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 8.130 528.193 1,56 12,30 99.999 6.496.774
2014-05-30 2014-05-28 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -13.750 41.250 -25,00
2014-05-30 2014-05-28 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -6.484 520.063 -1,23 45,74 -296.578 23.787.682
2014-05-30 2014-05-28 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 13.750 526.547 2,68
2014-05-22 2014-05-22 4 NBIX NEUROCRINE BIOSCIENCES INC
Stock Option
A - Award 15.000 15.000
2014-05-22 2014-05-21 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -8.125 16.250 -33,33
2014-05-22 2014-05-21 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -3.831 512.797 -0,74 44,48 -170.403 22.809.211
2014-05-22 2014-05-21 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8.125 516.628 1,60
2014-05-22 2014-05-20 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -8.125 8.125 -50,00
2014-05-22 2014-05-20 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -3.831 508.503 -0,75 43,98 -168.487 22.363.962
2014-05-22 2014-05-20 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8.125 512.334 1,61
2014-05-20 2014-05-17 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -8.125 0 -100,00
2014-05-20 2014-05-17 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -3.831 504.209 -0,75 43,59 -166.993 21.978.470
2014-05-20 2014-05-17 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8.125 508.040 1,63
2014-05-14 2014-05-12 4 NBIX NEUROCRINE BIOSCIENCES INC
Stock Option
M - Exercise -12.000 0 -100,00
2014-05-14 2014-05-12 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
F - Taxes -10.258 3.273 -75,81 14,47 -148.433 47.360
2014-05-14 2014-05-12 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 12.000 13.531 783,80 12,37 148.440 167.378
2014-03-05 2014-03-03 4 ALKS Alkermes plc.
Restricted Stock Unit Award
A - Award 52.000 52.000
2014-03-05 2014-03-03 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 230.000 230.000
2013-12-09 2013-12-05 4 XLRN ACCELERON PHARMA INC
Option to Purchase Common Stock
A - Award 20.000 20.000
2013-11-19 2013-11-18 4 ALKS Alkermes plc.
Restricted Stock Award
M - Exercise -125.000 0 -100,00
2013-11-19 2013-11-18 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -59.001 499.915 -10,56 36,89 -2.176.547 18.441.864
2013-11-19 2013-11-18 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 125.000 558.916 28,81
2013-09-18 3 XLRN ACCELERON PHARMA INC
Common Stock
28.750
2013-08-14 2013-08-12 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -34.125 0 -100,00
2013-08-14 2013-08-12 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -34.125 433.916 -7,29 33,26 -1.135.141 14.433.869
2013-08-14 2013-08-12 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 34.125 468.041 7,86 12,16 414.960 5.691.379
2013-08-05 2013-08-05 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -49.625 0 -100,00
2013-08-05 2013-08-05 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -50.000 34.125 -59,44
2013-08-05 2013-08-05 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -10.700 433.916 -2,41 35,41 -378.867 15.364.141
2013-08-05 2013-08-05 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -88.925 444.616 -16,67 34,85 -3.098.681 15.493.089
2013-08-05 2013-08-05 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 49.625 533.541 10,25 14,57 723.036 7.773.692
2013-08-05 2013-08-05 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50.000 483.916 11,52 12,16 608.000 5.884.419
2013-07-09 2013-07-08 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -50.000 84.125 -37,28
2013-07-09 2013-07-08 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -50.000 84.125 -37,28
2013-07-09 2013-07-08 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -50.000 433.916 -10,33 28,19 -1.409.735 12.234.131
2013-07-09 2013-07-08 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -50.000 433.916 -10,33 28,19 -1.409.735 12.234.131
2013-07-09 2013-07-08 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50.000 483.916 11,52 12,16 608.000 5.884.419
2013-07-09 2013-07-08 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50.000 483.916 11,52 14,57 728.500 7.050.656
2013-07-02 2013-07-01 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -50.000 134.125 -27,16
2013-07-02 2013-07-01 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -50.000 134.125 -27,16
2013-07-02 2013-07-01 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -50.000 433.916 -10,33 29,84 -1.492.050 12.948.487
2013-07-02 2013-07-01 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -50.000 433.916 -10,33 29,84 -1.492.050 12.948.487
2013-07-02 2013-07-01 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50.000 483.916 11,52 12,16 608.000 5.884.419
2013-07-02 2013-07-01 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50.000 483.916 11,52 14,57 728.500 7.050.656
2013-06-07 2013-06-05 4 EPZM Epizyme, Inc.
Stock Option (right to buy)
A - Award 17.666 17.666
2013-05-30 3 EPZM Epizyme, Inc.
Common Stock
60.000
2013-05-29 2013-05-28 4 ALKS Alkermes plc.
Restricted Stock Unit Award
A - Award 55.000 55.000
2013-05-29 2013-05-28 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 300.000 300.000
2013-05-23 2013-05-23 4 NBIX NEUROCRINE BIOSCIENCES INC
Stock Option
A - Award 15.000 15.000
2013-05-22 2013-05-21 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -8.125 24.375 -25,00
2013-05-22 2013-05-21 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -3.835 433.916 -0,88 31,98 -122.643 13.876.634
2013-05-22 2013-05-21 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8.125 437.751 1,89
2013-05-21 2013-05-20 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -8.125 16.250 -33,33
2013-05-21 2013-05-20 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -3.835 429.626 -0,88 31,04 -119.038 13.335.591
2013-05-21 2013-05-20 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8.125 433.461 1,91
2013-05-21 2013-05-17 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -8.125 8.125 -50,00
2013-05-21 2013-05-17 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -3.836 425.336 -0,89 31,69 -121.563 13.478.898
2013-05-21 2013-05-17 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8.125 429.172 1,93
2013-04-01 2013-03-28 4 NBIX NEUROCRINE BIOSCIENCES INC
Stock Option
M - Exercise -12.000 0 -100,00
2013-04-01 2013-03-28 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
F - Taxes -10.469 1.531 -87,24 12,15 -127.198 18.602
2013-04-01 2013-03-28 4 NBIX NEUROCRINE BIOSCIENCES INC
Common Stock
M - Exercise 12.000 12.000 10,60 127.200 127.200
2013-02-26 2013-02-25 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -16.250 0 -100,00
2013-02-26 2013-02-25 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -16.250 421.047 -3,72 20,72 -336.654 8.722.915
2013-02-26 2013-02-25 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 16.250 437.297 3,86 9,97 162.012 4.359.851
2013-02-20 2013-02-19 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -50.000 16.250 -75,47
2013-02-20 2013-02-19 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -50.000 421.047 -10,61 20,96 -1.048.155 8.826.450
2013-02-20 2013-02-19 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50.000 471.047 11,88 9,97 498.500 4.696.339
2013-01-23 2013-01-22 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -50.000 66.250 -43,01
2013-01-23 2013-01-22 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -50.000 421.047 -10,61 22,30 -1.114.775 9.387.453
2013-01-23 2013-01-22 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 50.000 471.047 11,88 9,97 498.500 4.696.339
2013-01-15 2013-01-14 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -39.970 116.250 -25,59
2013-01-15 2013-01-14 4 ALKS Alkermes plc.
Incentive Stock Option (Right to Buy)
M - Exercise X -10.030 0 -100,00
2013-01-15 2013-01-14 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -50.000 421.047 -10,61 21,91 -1.095.650 9.226.403
2013-01-15 2013-01-14 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 39.970 471.047 9,27 9,97 398.501 4.696.339
2013-01-15 2013-01-14 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 10.030 431.077 2,38 9,97 99.999 4.297.838
2012-11-19 2012-11-18 4 ALKS Alkermes plc.
Restricted Stock Award
M - Exercise -125.000 125.000 -50,00
2012-11-19 2012-11-18 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -52.126 421.047 -11,02 19,49 -1.015.936 8.206.206
2012-11-19 2012-11-18 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 125.000 473.173 35,90
2012-11-14 2012-11-12 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -12.100 0 -100,00
2012-11-14 2012-11-12 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -12.100 348.173 -3,36 20,25 -244.966 7.048.797
2012-11-14 2012-11-12 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 12.100 360.273 3,48 7,36 89.056 2.651.609
2012-10-19 2012-10-17 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -2.900 12.100 -19,33
2012-10-19 2012-10-17 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -2.900 348.173 -0,83 20,00 -58.000 6.963.460
2012-10-19 2012-10-17 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 2.900 351.073 0,83 7,36 21.344 2.583.897
2012-10-09 2012-10-09 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -41.900 15.000 -73,64
2012-10-09 2012-10-09 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -41.900 348.173 -10,74 20,31 -850.939 7.070.976
2012-10-09 2012-10-09 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 41.900 390.073 12,03 7,36 308.384 2.870.937
2012-10-09 2012-10-08 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -58.100 56.900 -50,52
2012-10-09 2012-10-08 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -58.100 348.173 -14,30 20,57 -1.195.384 7.163.520
2012-10-09 2012-10-08 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 58.100 406.273 16,69 7,36 427.616 2.990.169
2012-10-03 2012-10-01 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -100.000 115.000 -46,51
2012-10-03 2012-10-01 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -100.000 348.173 -22,31 20,52 -2.051.660 7.143.326
2012-10-03 2012-10-01 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 100.000 448.173 28,72 7,36 736.000 3.298.553
2012-09-26 2012-09-24 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -100.000 215.000 -31,75
2012-09-26 2012-09-24 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -100.000 348.173 -22,31 20,72 -2.072.500 7.215.885
2012-09-26 2012-09-24 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 100.000 448.173 28,72 7,36 736.000 3.298.553
2012-07-09 2012-07-09 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -61.801 0 -100,00
2012-07-09 2012-07-09 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -61.801 348.173 -15,07 17,52 -1.082.871 6.100.652
2012-07-09 2012-07-09 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 61.801 409.974 17,75 4,77 294.791 1.955.576
2012-07-06 2012-07-05 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -7.900 61.801 -11,33
2012-07-06 2012-07-05 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -7.900 348.173 -2,22 18,01 -142.309 6.271.919
2012-07-06 2012-07-05 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 7.900 356.073 2,27 4,77 37.683 1.698.468
2012-07-06 2012-07-03 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -30.299 69.701 -30,30
2012-07-06 2012-07-03 4 ALKS Alkermes plc.
Ordinary Shares
S - Sale X -30.299 348.173 -8,01 18,00 -545.446 6.267.845
2012-07-06 2012-07-03 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise X 30.299 378.472 8,70 4,77 144.526 1.805.311
2012-05-29 2012-05-27 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -1.981 348.173 -0,57 16,14 -31.973 5.619.512
2012-05-24 2012-05-23 4 NBIX NEUROCRINE BIOSCIENCES INC
Stock Option
A - Award 15.000 15.000
2012-05-22 2012-05-21 4 ALKS Alkermes plc.
Restricted Stock Unit Award
A - Award 32.500 32.500
2012-05-22 2012-05-21 4 ALKS Alkermes plc.
Employee Stock Option (Right to Buy)
A - Award 450.000 450.000
2012-05-21 2012-05-20 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -8.125 24.375 -25,00
2012-05-21 2012-05-20 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -3.389 350.154 -0,96 16,42 -55.647 5.749.529
2012-05-21 2012-05-20 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8.125 353.543 2,35
2012-05-18 2012-05-17 4 ALKS Alkermes plc.
Restricted Stock Unit Award
M - Exercise -8.125 16.250 -33,33
2012-05-18 2012-05-17 4 ALKS Alkermes plc.
Ordinary Shares
F - Taxes -3.389 345.418 -0,97 16,71 -56.630 5.771.935
2012-05-18 2012-05-17 4 ALKS Alkermes plc.
Ordinary Shares
M - Exercise 8.125 348.807 2,38
2012-02-03 2012-02-01 4 ALKS Alkermes plc.
Incentive Stock Option (Right to Buy)
M - Exercise X -20.968 0 -100,00
2012-02-03 2012-02-01 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -4.032 100.000 -3,88
2012-02-03 2012-02-01 4 ALKS Alkermes plc.
Non Qualified Stock Option (Right to Buy)
M - Exercise X -35.000 315.000 -10,00
2012-02-03 2012-02-01 4 ALKS Alkermes plc.
Common Stock
S - Sale X -20.968 340.682 -5,80 18,83 -394.895 6.416.132
2012-02-03 2012-02-01 4 ALKS Alkermes plc.
Common Stock
M - Exercise X 20.968 361.650 6,15 4,77 100.017 1.725.070
2012-02-03 2012-02-01 4 ALKS Alkermes plc.
Common Stock
S - Sale X -4.032 340.682 -1,17 18,83 -75.935 6.416.132
2012-02-03 2012-02-01 4 ALKS Alkermes plc.
Common Stock
M - Exercise X 4.032 344.714 1,18 4,77 19.233 1.644.286
2012-02-03 2012-02-01 4 ALKS Alkermes plc.
Common Stock
S - Sale X -35.000 340.682 -9,32 18,83 -659.162 6.416.132
2012-02-03 2012-02-01 4 ALKS Alkermes plc.
Common Stock
M - Exercise X 35.000 375.682 10,27 7,36 257.600 2.765.020
2012-01-31 2012-01-27 4 ALKS Alkermes plc.
Restricted Stock Award
M - Exercise -25.000 0 -100,00
2012-01-31 2012-01-27 4 ALKS Alkermes plc.
Common Stock
F - Taxes -8.045 340.682 -2,31 19,10 -153.660 6.507.026
2012-01-31 2012-01-27 4 ALKS Alkermes plc.
Common Stock
M - Exercise 25.000 348.727 7,72
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)